Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
Dan Weiss
»
Comments
»
Single Comment
Dan Weiss
39
Followers
2
Following
You are currently following Dan Weiss
Stop Following
You are no longer following Dan Weiss
Profile
Articles (69)
Instablog (
2
)
Comments (80)
Lev Pharmaceutical: Bullish, Despite Delayed FDA Decision
[
View article
]
See news today. Looks like company is to be acquired by Viropharma for a 40% premium (with additional potential kickers)
Jul 15 13:01 pm
|
Rating:
0
0
All Comments by Dan Weiss »
Comments by Ticker
AAN
,
ACAD
,
ADG
,
AEHR
,
AEZS
,
AHBIF.PK
,
AKS
,
ALGT
,
ALKS
,
ALPMF.PK
,
ALTH
,
AMAG
,
AMGN
,
AMTD
,
ANW
,
APEI
,
APOL
,
APPY
,
ASCA
,
AVCA
,
AVNR
,
AZN
,
BAC
,
BGM
,
BGU
,
BGZ
,
BIEL.PK
,
BLK
,
BMTI
,
BMY
,
BRCM
,
CADX
,
CAT
,
CECO
,
CEPH
,
CHRW
,
COCO
,
COF
,
COH
,
CPD
,
CTIC
,
CYTR
,
DBA
,
DBC
,
DBO
,
DD
,
DIA
,
DIG
,
DJP
,
DTO
,
DUG
,
DV
,
DYAX
,
EAT
,
EEI
,
ENDP
,
EPR
,
ERX
,
ERY
,
ESI
,
ETN
,
EXPO
,
F
,
F-PS
,
FAS
,
FAZ
,
FCFS
,
FCJ
,
FCZ
,
FMD
,
FNM
,
FRE
,
FRED
,
GBM
,
GCC
,
GIGM
,
GILD
,
GKM
,
GLD
,
GMGMQ.PK
,
GMS
,
GMW
,
GOLD
,
GPM
,
GPS
,
GSC
,
GSG
,
GSK
,
GSP
,
GTXI
,
GXM
,
HAL
,
HBI
,
HBRF.OB
,
HCBK
,
HEB
,
HGM
,
IBM
,
ISLE
,
ISTA
,
IVV
,
KHD
,
KSK
,
KTEC
,
KVU
,
LEVP.OB
,
LL
,
LLY
,
LQD
,
MFLO
,
MIND
,
MOO
,
MRVL
,
MVCO
,
MYL
,
NAN
,
NBR
,
NDN
,
NEM
,
NGG
,
NINE
,
NOOF
,
NVO
,
NVS
,
NYT
,
PARD
,
PCR
,
PENN
,
PEZ
,
PFI
,
PLX
,
PM
,
PNR
,
POZN
,
PSDV
,
PSL
,
PXI
,
QQQQ
,
RGM
,
RMTI
,
RPTP.OB
,
SCX
,
SNDK
,
SNY
,
SPF
,
SPPI
,
SPY
,
STRA
,
SVNT
,
TBT
,
TEVA
,
TEX
,
THRX
,
TMW
,
TNA
,
TRMP
,
TXN
,
TZA
,
UA
,
USB
,
UTHR
,
VPHM
,
WPI
,
WPO
,
XGM
,
XLF
,
XNPT
,
XVF
Dan Weiss'
Comments Stats
80 comments
Rating:
8
(9
-
1 is
)
-
See news today. Looks like company is to be acquired by Viropharma for a 40% premium (with additional potential kickers)
Jul 15 13:01 pm
|Rating:
0
0
All Comments by Dan Weiss »Lev Pharmaceutical: Bullish, Despite Delayed FDA Decision [View article]